Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-01

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mycophenolate mofetil from Accord Healthcare Inc., updating the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)